Stephanie Schwalm

Stephanie Schwalm

Auto-generated profile, based on publicly available information

Stephanie Schwalm

University Hospital, pharmazentrum, Institute of General Pharmacology and Toxicology Goethe University Frankfurt am Main Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Neuropharmacology
Verified
Journal Article
Closed access
FIFaik Imeri
Faik Imeri
BTBisera Stepanovska Tanturovska
Bisera Stepanovska Tanturovska
AZAleksandra Zivkovic
Aleksandra Zivkovic
GEGaby Enzmann
Gaby Enzmann
SSStephanie Schwalm
Stephanie Schwalm
Andrea HuwilerAndrea Huwiler
Andrea Huwiler

25 June 2025 in The FASEB Journal
Verified
Journal Article
Open access
AOAnke Oftring
Anke Oftring
VWViktoria Wagner
Viktoria Wagner
DTDominique Thomas
Dominique Thomas
LHLisa Sophie Huber
Lisa Sophie Huber
GGGerd Geisslinger
Gerd Geisslinger
SSStephanie Schwalm
Stephanie Schwalm
Renal fibrosis is the final pathological outcome of chronic kidney disease and is characterized by an excessive accumulation of extracellular matrix (ECM), leading to tissue dysfunction and, ultimately, organ failure. In this study, we investigated the mechanism by which elevated intracellular sphingosine levels in sphingosine kinase 2‐deficient ( Sphk2 −/− ) fibroblasts and mice attenuate profibrotic TGF‐β signaling. Previously, we demonstrated that higher sphingosine levels suppress the expression of profibrotic factors in TGF‐β‐treated fibroblasts and a unilateral ureteral obstruction (UUO) mouse model by upregulating SMAD7, an inhibitor of TGF‐β/SMAD signaling. Here, we identified miR‐21 as a key post‐transcriptional regulator of SMAD7 and show that protein kinase C (PKC) inhibition—via sphingosine supplementation, SPHK2 depletion, or pharmacological PKC inhibitors—reduces miR‐21 expression. Mechanistically, this occurs through PKC‐dependent inhibition of AP1‐driven miR‐21 transcription. Analysis of human diabetic kidney tissue revealed a significant upregulation of miR‐21, contributing to ECM accumulation by suppressing SMAD7 protein expression, corroborating the critical role of miR‐21 in renal fibrosis. These findings suggest that targeting the sphingosine‐PKC‐miR‐21‐SMAD7 axis may offer a novel therapeutic approach for renal fibrosis.